바이오뱅크 시장(2026-2030년)

The global biobanking market is forecasted to grow by USD 1993.8 mn during 2025-2030, accelerating at a CAGR of 9.2% during the forecast period. The report on the global biobanking market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic and genetic diseases, growing investments in precision medicine research programs, expanding drug discovery and clinical research activities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global biobanking market is segmented as below:

By Type

• Physical
• Virtual

By Product

• Equipment
• Consumables

By End-User

• Pharma and biotech companies
• Academic and research institutes
• Hospitals and clinics
• Contract research organizations

Geography

• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• North America
  • US
  • Canada
  • Mexico
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the accelerating integration of ai-enabled biobank data analytics as one of the prime reasons driving the global biobanking market growth during the next few years. Also, growing emphasis on participant-centric sample governance and increasing adoption of automated sample processing workflows will lead to sizable demand in the market.

The report on the global biobanking market covers the following areas:

• Global biobanking market sizing
• Global biobanking market forecast
• Global biobanking market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global biobanking market vendors that include Agilent Technologies Inc., Angelantoni Industrie S.p.A., Avantor Inc., Azenta Inc., Becton Dickinson and Co., BioLife Solutions Inc., Chart Industries Inc., ELPRO BUCHS AG, Eppendorf SE, Greiner AG, Haier Biomedical, Hamilton Co., Helmer Scientific Inc., Merck KGaA, PHC Holdings Corp., QIAGEN N.V., Revvity Inc., Sartorius AG, STEMCELL Technologies Inc., Tecan Trading AG, Thermo Fisher Scientific Inc.. Also, the global biobanking market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Biobanking Market 2020 - 2024
  • Historic Market Size - Data Table on Global Biobanking Market 2020 - 2024 ($ million)
• 5.2 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
• 5.3 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.4 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global biobanking market
• 6.2 Impact of geopolitical conflicts on global biobanking market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Type

• 8.1 Market segments
• 8.2 Comparison by Type
• 8.3 Physical - Market size and forecast 2025-2030
• 8.4 Virtual - Market size and forecast 2025-2030
• 8.5 Market opportunity by Type
  • Market opportunity by Type ($ million)

9 Market Segmentation by Product

• 9.1 Market segments
• 9.2 Comparison by Product
• 9.3 Equipment - Market size and forecast 2025-2030
• 9.4 Consumables - Market size and forecast 2025-2030
• 9.5 Market opportunity by Product
  • Market opportunity by Product ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
• 10.2 Comparison by End-user
• 10.3 Pharma and biotech companies - Market size and forecast 2025-2030
• 10.4 Academic and research institutes - Market size and forecast 2025-2030
• 10.5 Hospitals and clinics - Market size and forecast 2025-2030
• 10.6 Contract research organizations - Market size and forecast 2025-2030
• 10.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 Europe - Market size and forecast 2025-2030
  • 12.3.1 Germany - Market size and forecast 2025-2030
  • 12.3.2 UK - Market size and forecast 2025-2030
  • 12.3.3 France - Market size and forecast 2025-2030
  • 12.3.4 Italy - Market size and forecast 2025-2030
  • 12.3.5 Spain - Market size and forecast 2025-2030
  • 12.3.6 The Netherlands - Market size and forecast 2025-2030
• 12.4 North America - Market size and forecast 2025-2030
  • 12.4.1 US - Market size and forecast 2025-2030
  • 12.4.2 Canada - Market size and forecast 2025-2030
  • 12.4.3 Mexico - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Thailand - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 South Africa - Market size and forecast 2025-2030
  • 12.6.5 Turkey - Market size and forecast 2025-2030
  • 12.6.6 Argentina - Market size and forecast 2025-2030
  • 12.6.7 Colombia - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Increasing prevalence of chronic and genetic diseases
  • Growing investments in precision medicine research programs
  • Expanding drug discovery and clinical research activities
• 13.2 Market challenges
  • Regulatory heterogeneity across cross-border biospecimen exchange
  • Ethical and privacy risks in long-term biological data management
  • High operational costs for cryogenic storage infrastructure
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Accelerating integration of AI-enabled biobank data analytics
  • Growing emphasis on participant-centric sample governance
  • Increasing adoption of automated sample processing workflows

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
  • SWOT
• 15.5 Avantor Inc.
  • Avantor Inc. - Overview
  • Avantor Inc. - Business segments
  • Avantor Inc. - Key news
  • Avantor Inc. - Key offerings
  • Avantor Inc. - Segment focus
  • SWOT
• 15.6 Azenta Inc.
  • Azenta Inc. - Overview
  • Azenta Inc. - Business segments
  • Azenta Inc. - Key offerings
  • Azenta Inc. - Segment focus
  • SWOT
• 15.7 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key news
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 15.8 Chart Industries Inc.
  • Chart Industries Inc. - Overview
  • Chart Industries Inc. - Business segments
  • Chart Industries Inc. - Key offerings
  • Chart Industries Inc. - Segment focus
  • SWOT
• 15.9 Eppendorf SE
  • Eppendorf SE - Overview
  • Eppendorf SE - Product / Service
  • Eppendorf SE - Key offerings
  • SWOT
• 15.10 Haier Biomedical
  • Haier Biomedical - Overview
  • Haier Biomedical - Product / Service
  • Haier Biomedical - Key offerings
  • SWOT
• 15.11 Hamilton Co.
  • Hamilton Co. - Overview
  • Hamilton Co. - Product / Service
  • Hamilton Co. - Key offerings
  • SWOT
• 15.12 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
  • SWOT
• 15.13 PHC Holdings Corp.
  • PHC Holdings Corp. - Overview
  • PHC Holdings Corp. - Business segments
  • PHC Holdings Corp. - Key offerings
  • PHC Holdings Corp. - Segment focus
  • SWOT
• 15.14 QIAGEN N.V.
  • QIAGEN N.V. - Overview
  • QIAGEN N.V. - Product / Service
  • QIAGEN N.V. - Key offerings
  • SWOT
• 15.15 Revvity Inc.
  • Revvity Inc. - Overview
  • Revvity Inc. - Business segments
  • Revvity Inc. - Key offerings
  • Revvity Inc. - Segment focus
  • SWOT
• 15.16 Sartorius AG
  • Sartorius AG - Overview
  • Sartorius AG - Business segments
  • Sartorius AG - Key offerings
  • Sartorius AG - Segment focus
  • SWOT
• 15.17 Tecan Trading AG
  • Tecan Trading AG - Overview
  • Tecan Trading AG - Business segments
  • Tecan Trading AG - Key offerings
  • Tecan Trading AG - Segment focus
  • SWOT
• 15.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations